Characterization of the novel HLA-DRB3*02:193 allele by sequencing-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
11 2023
Historique:
revised: 27 07 2023
received: 20 07 2023
accepted: 31 07 2023
medline: 10 10 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

HLA-DRB3*02:193 differs from DRB3*02:02:01:11 by one nucleotide substitution in exon 1, and intronic changes.

Identifiants

pubmed: 37607130
doi: 10.1111/tan.15186
doi:

Substances chimiques

HLA-DRB3 Chains 0
HLA-DRB1 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-643

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. The IPD-IMGT/HLA database. Nucleic Acids Res. 2023;51(D1):D1053-D1060. doi:10.1093/nar/gkac1011
Teufel F, Almagro Armenteros JJ, Johansen AR, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40(7):1023-1025. doi:10.1038/s41587-021-01156-3
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455. doi:10.1111/j.1399-0039.2010.01466.x

Auteurs

Lucie Blandin (L)

Histocompatibility and Immunogenetics laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Jean Milhes (J)

CHU de Toulouse, Laboratoire d'immunologie, Hôpital Purpan, Toulouse, France.

Nicolas Congy-Jolivet (N)

CHU de Toulouse, Laboratoire d'immunologie, Hôpital Purpan, Toulouse, France.
CRCT, INSERM UMR 1037, University Toulouse III, Toulouse, France.

Richard Lemal (R)

Histocompatibility and Immunogenetics laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.

Paul Rouzaire (P)

Histocompatibility and Immunogenetics laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH